08:00 , Jan 21, 2010 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

This week in techniques Approach Summary Licensing status Publication and contact information Drug platforms mAb-producing, immortalized memory B cells A method to isolate and immortalize antibody-producing memory B cells could provide a way to rapidly...
08:00 , Jan 14, 2010 |  BC Innovations  |  Tools & Techniques

Making mAbs en masse

A primary goal for antibody makers is capturing the full diversity of mAbs generated by the human immune system, then isolating and cloning individual memory cells that produce mAbs against a particular antigen. But harnessing...
08:00 , Nov 9, 2009 |  BC Week In Review  |  Company News

Calmune, Crucell deal

Calmune will use its SEBVI technology to generate human mAbs against an undisclosed infectious disease target for Crucell. SEBV1 technology allows high-affinity, fully human antibodies against microbial targets to be efficiently recovered from Epstein Barr...